326 related articles for article (PubMed ID: 18791329)
21. Coronary artery disease following bone marrow transplantation.
Chan KW; Taylor GP; Shepherd JD; Shepherd WE
Bone Marrow Transplant; 1989 May; 4(3):327-30. PubMed ID: 2659118
[TBL] [Abstract][Full Text] [Related]
22. Herpes simplex thymidine kinase (HStk) transgenic donor lymphocytes.
Burt RK; Drobyski WR; Traynor AE; Link CJ
Bone Marrow Transplant; 1999 Nov; 24(10):1043-51. PubMed ID: 10578153
[TBL] [Abstract][Full Text] [Related]
23. Fatal GVHD demonstrating an involvement of respiratory muscle following donor leukocyte transfusion (DLT).
Oshima Y; Takahashi S; Nagayama H; Nishiwaki K; Kobayashi Y; Tojo A; Okamoto S; Tani K; Ozawa K; Wakabayashi T; Sato N; Kobayashi S; Nakamura K; Ohya Y; Nukina N; Kanazawa I; Asano S
Bone Marrow Transplant; 1997 Apr; 19(7):737-40. PubMed ID: 9156252
[TBL] [Abstract][Full Text] [Related]
24. [A case of eosinophilic pneumonia which occurred after bone marrow transplantation for acute myeloid leukemia].
Furuta K; Taki M; Murase H; Nakagawa A; Nishiyama H; Nohgawa M
Nihon Kokyuki Gakkai Zasshi; 2011 Jan; 49(1):20-4. PubMed ID: 21384677
[TBL] [Abstract][Full Text] [Related]
25. Dynamics in chimerism of T cells and dendritic cells in relapsed CML patients and the influence on the induction of alloreactivity following donor lymphocyte infusion.
Levenga H; Woestenenk R; Schattenberg AV; Maas F; Jansen JH; Raymakers R; De Mulder PH; van de Wiel-van Kemenade E; Schaap N; de Witte T; Dolstra H
Bone Marrow Transplant; 2007 Sep; 40(6):585-92. PubMed ID: 17637687
[TBL] [Abstract][Full Text] [Related]
26. Factors for graft-versus-host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell dose.
Fozza C; Szydlo RM; Abdel-Rehim MM; Nadal E; Goldman JM; Apperley JF; Dazzi F
Br J Haematol; 2007 Mar; 136(6):833-6. PubMed ID: 17341269
[TBL] [Abstract][Full Text] [Related]
27. Modulating graft-versus-host disease to enhance the graft-versus-leukemia effect.
Alyea EP
Best Pract Res Clin Haematol; 2008 Jun; 21(2):239-50. PubMed ID: 18503989
[TBL] [Abstract][Full Text] [Related]
28. Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation.
Loren AW; Porter DL
Bone Marrow Transplant; 2008 Mar; 41(5):483-93. PubMed ID: 18026156
[TBL] [Abstract][Full Text] [Related]
29. Exanthema and enanthema in graft versus host disease (GVHD).
Suzuki M; Kikkawa Y; Hasegawa T; Kaneko F
Fukushima J Med Sci; 1993 Dec; 39(2):101-7. PubMed ID: 7927132
[TBL] [Abstract][Full Text] [Related]
30. Steroid-responsive chronic hepatic graft-versus-host disease without extrahepatic graft-versus-host disease.
Gholson CF; Yau JC; LeMaistre CF; Cleary KR
Am J Gastroenterol; 1989 Oct; 84(10):1306-9. PubMed ID: 2801684
[TBL] [Abstract][Full Text] [Related]
31. [Secondary eosinophilia in a patient with hypereosinophilic syndrome after allogeneic bone marrow transplantation from a sibling donor].
Ito C; Tsuboi K; Yoshiba F; Kubota N; Tazume K; Oki M; Tsuchiya T; Ohmachi K; Kikuchi A; Shimakura Y; Ando K; Kishi K; Yonekura S; Hotta T
Rinsho Ketsueki; 2001 Jun; 42(6):496-501. PubMed ID: 11505529
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of refractory donor lymphocyte infusion-induced immune-mediated pancytopenia with rituximab.
Kato I; Umeda K; Awaya T; Yui Y; Niwa A; Fujino H; Matsubara H; Watanabe K; Heike T; Adachi N; Endo F; Mizukami T; Nunoi H; Nakahata T; Adachi S
Pediatr Blood Cancer; 2010 Feb; 54(2):329-31. PubMed ID: 19890900
[TBL] [Abstract][Full Text] [Related]
33. Maintenance immunotherapy by repetitive low-dose donor lymphocytes infusions in a child with relapse state aml after allogeneic stem cell transplantation.
Hartwig M; Weigel S; Bernig T; Bader P; Dölken R; Beck J
Pediatr Hematol Oncol; 2007 Mar; 24(2):137-40. PubMed ID: 17454780
[TBL] [Abstract][Full Text] [Related]
34. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
Olson KA; West K; McCarthy PL
Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567
[TBL] [Abstract][Full Text] [Related]
35. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
Prigozhina TB; Elkin G; Khitrin S; Slavin S
Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
[TBL] [Abstract][Full Text] [Related]
36. Donor lymphocyte infusion. An adaptive cellular immunotherapy for treatment of hematological malignancies.
Owaidah TM
Saudi Med J; 2003 Feb; 24(2):138-41. PubMed ID: 12682675
[TBL] [Abstract][Full Text] [Related]
37. Staphylococcal scalded skin syndrome mimicking acute graft-vs-host disease in a bone marrow transplant recipient.
Goldberg NS; Ahmed T; Robinson B; Ascensao J; Horowitz H
Arch Dermatol; 1989 Jan; 125(1):85-7. PubMed ID: 2642684
[TBL] [Abstract][Full Text] [Related]
38. Successful treatment of JMML relapsed after unrelated allogeneic transplant with cytoreduction followed by DLI and interferon-alpha: evidence for a graft-versus-leukemia effect in non-monosomy-7 JMML.
Pulsipher MA; Adams RH; Asch J; Petersen FB
Bone Marrow Transplant; 2004 Jan; 33(1):113-5. PubMed ID: 14704663
[TBL] [Abstract][Full Text] [Related]
39. An unusual case of intrapulmonary granulocytic sarcoma presenting as interstitial pneumonitis following allogeneic bone marrow transplantation for acute myeloid leukaemia and responding to donor lymphocyte infusion.
Kottaridis PD; Ketley N; Peggs K; Chakraverty R; Ralleigh G; Shaw P; Pezzella F; Goldstone AH; Devereux S; Mackinnon S
Bone Marrow Transplant; 1999 Oct; 24(7):807-9. PubMed ID: 10516687
[TBL] [Abstract][Full Text] [Related]
40. Esophageal graft versus host disease.
Sodhi SS; Srinivasan R; Thomas RM
Gastrointest Endosc; 2000 Aug; 52(2):235. PubMed ID: 10922099
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
